Andrew Gengos - 07 Oct 2025 Form 3 Insider Report for Turn Therapeutics Inc. (TTRX)

Role
Director
Signature
/s/ Zuraiz Chaudhary, attorney-in-fact for Andrew Gengos
Issuer symbol
TTRX
Transactions as of
07 Oct 2025
Net transactions value
$0
Form type
3
Filing time
07 Oct 2025, 19:02:12 UTC
Previous filing
30 Jun 2025
Next filing
10 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gengos Andrew Director C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE /s/ Zuraiz Chaudhary, attorney-in-fact for Andrew Gengos 07 Oct 2025 0001563623

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TTRX Stock Option (right to buy) 07 Oct 2025 Common Stock 508,934 $3.54 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option became exercisable as to 1/4 of the shares of common stock underlying the stock option on January 1, 2021, and 1/36 of the shares on the first day of each month thereafter.
F2 The number of shares of common stock underlying the stock option and the applicable exercise price give effect to the 2-for-1 forward stock split, that took effect on September 30, 2025.

Remarks:

Exhibit 24 - Power of Attorney